The VHL Alliance Competitive Research Grant Program funds innovative research to advance understanding, detection, and treatment of Von Hippel-Lindau (VHL) disease.
Funder: VHL Alliance
Due Dates (Anticipated): November 2026 (Letter of Intent) | February 2027 (Full application)
Funding Amounts: Pilot Grant: $25,000 (1 year) | Research Grant: $100,000 (2 years) | Postdoctoral Fellowship: $100,000 (2 years)
Summary: Supports innovative research advancing understanding, detection, and treatment of Von Hippel-Lindau (VHL) disease.
Key Information: International applicants are welcome; multiple grant mechanisms available annually.
The VHL Alliance Competitive Research Grant Program funds innovative scientific studies focused on Von Hippel-Lindau (VHL) disease. As the leading global funder in this field, the program aims to deepen understanding of VHL mechanisms, improve diagnostic and therapeutic strategies, and drive progress toward a cure. Grants are awarded annually to support projects that address critical questions in VHL biology, detection, and treatment, with an emphasis on projects that could significantly impact patient care and outcomes.